(Total Views: 701)
Posted On: 07/28/2022 8:05:08 AM
Post# of 154082
Here is the transcript of the GSK quarter 2, 2022 conference call. There was no mention of either Leronlimab or Cytodyn.
https://www.marketscreener.com/quote/stock/GS...-41103550/
https://www.marketscreener.com/quote/stock/GS...-41103550/

